6330 related articles for article (PubMed ID: 3559628)
21. Influence of 2-chloro-2'-deoxyadenosine alone and in combination with cyclophosphamide or methotrexate on murine leukemia L1210.
Góra-Tybor J; Robak T; Warzocha K; Grieb P
Arch Immunol Ther Exp (Warsz); 1994; 42(1):39-42. PubMed ID: 7503633
[TBL] [Abstract][Full Text] [Related]
22. The antitumor effect of postoperative treatment with genistein alone or combined with cyclophosphamide in mice bearing transplantable tumors.
Wietrzyk J; Opolski A; Madej J; Radzikowski C
Acta Pol Pharm; 2000 Nov; 57 Suppl():5-8. PubMed ID: 11293263
[TBL] [Abstract][Full Text] [Related]
23. L-histidinol: preclinical therapeutic studies in combination with antitumor agents and pharmacokinetic studies in mice.
Zaharko D; Plowman J; Waud W; Dykes D; Malspeis L
Cancer Res; 1992 Jul; 52(13):3604-9. PubMed ID: 1617631
[TBL] [Abstract][Full Text] [Related]
24. [Combined effect of HO-221 with various antitumor agents against L 1210 leukemia].
Nakajima T; Masuda H; Okamoto T; Watanabe M; Yokoyama K; Yamada N; Tsukagoshi S; Taguchi T
Gan To Kagaku Ryoho; 1991 Apr; 18(4):555-62. PubMed ID: 2012397
[TBL] [Abstract][Full Text] [Related]
25. Antileukemic effects of recombinant human tumor necrosis factor alpha (rh-TNF alpha) with cyclophosphamide or methotrexate on leukemia L1210 and leukemia P388 in mice.
Warzocha K; Robak T
Acta Haematol Pol; 1992; 23(1):55-62. PubMed ID: 1615753
[TBL] [Abstract][Full Text] [Related]
26. Synthesis, physical properties, and antitumor activity of tetraplatin and related tetrachloroplatinum(IV) stereoisomers of 1,2-diaminocyclohexane.
Anderson WK; Quagliato DA; Haugwitz RD; Narayanan VL; Wolpert-DeFilippes MK
Cancer Treat Rep; 1986 Aug; 70(8):997-1002. PubMed ID: 3731155
[TBL] [Abstract][Full Text] [Related]
27. Chemoimmunotherapy of L1210 leukemia with adriamycin, cyclophosphamide, and OK-432, and their effects on the generation of antitumor immunity.
Ujiie T
Jpn J Cancer Res; 1987 Jul; 78(7):737-47. PubMed ID: 3114200
[TBL] [Abstract][Full Text] [Related]
28. Studies on the antitumor activities of pyrimidinone-interferon inducers. I. Effect against artificial and spontaneous lung metastases of murine tumors.
Milas L; Hersh EM; Stringfellow DA; Hunter N
J Natl Cancer Inst; 1982 Jan; 68(1):139-45. PubMed ID: 6172625
[TBL] [Abstract][Full Text] [Related]
29. The effect of high-dose thiotepa, alone or in combination with other chemotherapeutic agents, on a murine B-cell leukemia model simulating autologous stem cell transplantation.
Abdul-Hai A; Weiss L; Ergas D; Resnick IB; Slavin S; Shapira MY
Bone Marrow Transplant; 2007 Nov; 40(9):891-6. PubMed ID: 17768389
[TBL] [Abstract][Full Text] [Related]
30. Antitumor, nephrotoxic and clastogenic effect of cis-DDP with DDTC or NAC.
Konstantinov S; Topashka-Ancheva M; Karaivanova M; Zoneva G; Galova I
Neoplasma; 1994; 41(5):253-8. PubMed ID: 7854494
[TBL] [Abstract][Full Text] [Related]
31. Combined therapy of L1210 leukemia with Damvar and cytostatics.
Pujman V; Cernochová S
Neoplasma; 1979; 26(5):521-3. PubMed ID: 522924
[TBL] [Abstract][Full Text] [Related]
32. Combinations of mesna with cyclophosphamide or adriamycin in the treatment of mice with tumors.
Bernacki RJ; Bansal SK; Gurtoo HL
Cancer Res; 1987 Feb; 47(3):799-802. PubMed ID: 3100025
[TBL] [Abstract][Full Text] [Related]
33. Antineoplastic activity of azacarbazoles. I. Synthesis and antitumor properties of alpha-carboline and its selected derivatives.
Wieczorek J; Peczyńska-Czoch W; Mordarski M; Kaczmarek L; Nantka-Namirski P
Arch Immunol Ther Exp (Warsz); 1986; 34(3):315-21. PubMed ID: 3592935
[TBL] [Abstract][Full Text] [Related]
34. Enhanced antitumor immune responses of IL-2 gene-modified tumor vaccine by combination with IL-1 and low dose cyclophosphamide.
Cao X; Zhang W; Wan T; Yu Y; Tao Q; Wang J
J Exp Clin Cancer Res; 1999 Jun; 18(2):173-9. PubMed ID: 10464704
[TBL] [Abstract][Full Text] [Related]
35. Chemotherapy of advanced L1210 leukemia with platinum compounds in combination with other antitumor agents.
Gale GR; Atkins LM; Meischen SJ; Smith AB; Walker EM
Cancer Treat Rep; 1977; 61(3):445-50. PubMed ID: 872142
[TBL] [Abstract][Full Text] [Related]
36. Biochemical and pharmacologic study of therapeutic synergism with cyclophosphamide plus methotrexate in murine L1210 leukemia.
Klubes P; Cerna I
Cancer Treat Rep; 1981; 65(1-2):107-14. PubMed ID: 7226161
[TBL] [Abstract][Full Text] [Related]
37. [Effect of biological response modifier sulfoethylated (1 --> 3)-beta-D-glycan on the experimental leukemia in mice].
Khalikova TA; Korolenko TA
Eksp Klin Farmakol; 2006; 69(5):39-43. PubMed ID: 17153965
[TBL] [Abstract][Full Text] [Related]
38. Antitumor properties of 2(1H)-pyrimidinone riboside (zebularine) and its fluorinated analogues.
Driscoll JS; Marquez VE; Plowman J; Liu PS; Kelley JA; Barchi JJ
J Med Chem; 1991 Nov; 34(11):3280-4. PubMed ID: 1956046
[TBL] [Abstract][Full Text] [Related]
39. Anti-tumor efficacy of Cloretazine (VNP40101M) alone and in combination with fludarabine in murine tumor and human xenograft tumor models.
Zheng LM; Li Z; Liu L; Song BL; King I
Cancer Chemother Pharmacol; 2007 Jun; 60(1):45-51. PubMed ID: 17256135
[TBL] [Abstract][Full Text] [Related]
40. Antitumour and antimetastatic effect of genistein alone or combined with cyclophosphamide in mice transplanted with various tumours depends on the route of tumour transplantation.
Wietrzyk J; Opolski A; Madej J; Radzikowski C
In Vivo; 2000; 14(2):357-62. PubMed ID: 10836210
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
